Search Results 1551-1560 of 17118 for monoclonal antibody

1. Mayo Clinic-led Team Identifies Master Switch for Cancer-Causing HER2 Protein

   They are also investigating drugs — such as mimetic agents, targeted antibodies and small molecules — that could specifically block this site responsible for ...

2. Autoimmune epilepsy - Care at Mayo Clinic

   Mayo Clinic Laboratories was one of the first centers to offer an autoimmune encephalitis panel to check for antibodies and test for autoimmune epilepsy.

3. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

   ... antibodies). No HIV testing ... History of or active hepatitis B (hepatitis B surface antigen reactive) or active hepatitis C (hepatitis C virus antibody).

4. Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and Associated Precursors - Mayo Clinic

   Monoclonal B-cell lymphocytosis. Chronic lymphocytic leukemia/small lymphocytic lymphoma. B-cell Non-Hodgkin's lymphoma: Follicular lymphoma;; Mantle cell ...

5. Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) - Mayo Clinic

   The purpose of this study is to establish a prospective cohort of individuals with precursor conditions to multiple myeloma, such as monoclonal gammopathy ...

6. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

   Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

7. AB-2100, an Integrated Circuit T (ICT) Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

   ... antibody-based agent). * Systemic anti-cancer therapy within 14 days of starting of conditioning chemotherapy (interval of 28 days will be required if the ...

8. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis - Mayo Clinic

   Secondary FGN (due to monoclonal gammopathy, autoimmune disease or malignancy). Presence of a secondary pathology on biopsy (e.g. diabetic nephropathy) ...

9. Clonal hematopoiesis clinic stratifies risk for patients with cancer

   The concept of early detection of pre-malignant states has been around for several years and was first defined as monoclonal gammopathy of undetermined ...

10. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Known history of hypersensitivity to or positive serum human anti-drug antibody (ADA) to a CD25 antibody. Allogenic or autologous transplant within 60 days ...